Doctors, researchers, scientists and patients alike are rapidly adopting XR applications to evolve healthcare as we know it. Augmented, virtual, and mixed reality are revolutionizing treatment and therapy, improving quality while cutting costs, and reducing risk during procedures. XR data science is shaping data visualization and providing solutions for biomedical processes and technologies. Research is also showing that immersive experiences could soon be prescribed as a means to treat everything from ADHD to Alzheimers. Attend sessions in XRDC's Healthcare Track to hear from developers, meet innovative healthcare practitioners, and identify business opportunities and partnerships in this rapidly growing sector.
In early 2018, for the first time, software is expected to be cleared by the FDA to be prescribed by doctors to treat children with ADHD, opening the $300 Billion annual US pharmaceutical market to game developers. Two other game-related treatments have already received FDA device clearance, a different type of clearance, and AR & VR creators are increasingly interested in this concept.
In this talk, you can learn specifics of three companies that have applied to get their (non-XR) games reviewed in FDA trials, hear the business, technical, creative, and scientific challenges involved in creating and testing this sort of game, and other opportunities for games as medicine that are opening in the near future.
This talk will also focus on why many XR-based Games for Health have not yet gotten FDA clearance, and possible solutions for this going forward. FDA review of software as treatment opens new markets for developers and provides positive news about the benefits of games, but also exposes them to more scrutiny. Come hear how to effectively deal with these opportunities and challenges
The Stanford CHARIOT Program is one of the largest clinical immersive technology programs in the world. They have used AR and VR to treat thousands of pediatric patients and are constantly exploring new ways to bring these technologies into the clinical environment. Using examples from real patients, this session will discuss the current state of AR/VR in pediatric care and offer critical insight into the unique challenges of designing for the healthcare environment.